Pneuma Respiratory, Inc
Pneuma Respiratory is a MedTech company dedicated to transforming inhaled drug delivery and harm reduction in nicotine use. Their innovative water-based aerosol technology aims to eliminate harmful toxins associated with heat and combustion in nicotine products, while also developing targeted therapies for lung diseases and cancer. With a focus on high-precision aerosol generation, their mission is to save lives and improve respiratory health globally.
Industries
Nr. of Employees
small (1-50)
Pneuma Respiratory, Inc
870 State Farm Rd, Boone, NC 28607, USA
Patents
Electronic breath actuated in-line droplet delivery device with small volume ampoule and methods of use
US-11771852-B2
View DetailsElectronic breath actuated in-line droplet delivery device and methods of use
US-11738158-B2
View Details
Electronic breath actuated in-line droplet delivery device with small volume ampoule and methods of use
US-11771852-B2
View DetailsElectronic breath actuated in-line droplet delivery device and methods of use
US-11738158-B2
View DetailsProducts
Reduced-risk, non-heated nicotine delivery consumer device
A consumer-facing inhalation device that uses water-based, non-heated aerosol generation with breath-actuated dosing and mobile app integration to support smoking cessation and harm reduction.
Pharmaceutical inhalation delivery platform
A device and formulation platform for precise pulmonary delivery of small molecules, biologics, vaccines, and other therapeutic classes, with low-shear aerosolization and digital dosing controls.
Reduced-risk, non-heated nicotine delivery consumer device
A consumer-facing inhalation device that uses water-based, non-heated aerosol generation with breath-actuated dosing and mobile app integration to support smoking cessation and harm reduction.
Pharmaceutical inhalation delivery platform
A device and formulation platform for precise pulmonary delivery of small molecules, biologics, vaccines, and other therapeutic classes, with low-shear aerosolization and digital dosing controls.
Services
Partnership-based R&D to co-develop inhaled small molecules and biologics, including program support for oncology and respiratory conditions.
Design and execution of aerosol emissions testing and composition analysis, coordinated with external analytical laboratories.
Prototype development, test-method development, fixturing, and pilot-line manufacturing iteration toward scaled production and supply-chain readiness.
Partnership-based R&D to co-develop inhaled small molecules and biologics, including program support for oncology and respiratory conditions.
Design and execution of aerosol emissions testing and composition analysis, coordinated with external analytical laboratories.
Prototype development, test-method development, fixturing, and pilot-line manufacturing iteration toward scaled production and supply-chain readiness.
Expertise Areas
- Inhaled therapeutics
- Aerosol physics and droplet engineering
- Low-shear delivery of biologics
- Analytical chemistry and formulation development
Key Technologies
- Vibrating-membrane / ejector aerosol generation
- Low-shear ejector aerosolization
- Water-based inhalation formulations
- Ultra-fine aerosol control (<1 µm droplet generation)
News & Updates
A groundbreaking study examining the aerosol composition of various nicotine delivery devices, highlighting the absence of concerning heavy metals and organic compounds in Pneuma’s non-heated system.
A study comparing the amounts of concerning compounds in emissions of inhaled nicotine products, showing Pneuma’s device had no quantifiable levels of heavy metals or organic compounds.
Patent US 11,793,945
Introduces the 'Push Mode' aerosol generation technology, covering device components for precise and efficient aerosolized treatments.
A groundbreaking study examining the aerosol composition of various nicotine delivery devices, highlighting the absence of concerning heavy metals and organic compounds in Pneuma’s non-heated system.
A study comparing the amounts of concerning compounds in emissions of inhaled nicotine products, showing Pneuma’s device had no quantifiable levels of heavy metals or organic compounds.
Patent US 11,793,945
Introduces the 'Push Mode' aerosol generation technology, covering device components for precise and efficient aerosolized treatments.